State of current therapy and patient care in Europe

International Journal of Clinical Practice, Supplement

Volumn , Issue 107, 1999, Pages 6-10

  Lefebvre, Pierre J ^a   Scheen, Andre J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

CONFERENCE PAPER; EUROPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRIORITY JOURNAL; ALGORITHM; REVIEW; STANDARD;

ALGORITHMS; DIABETES MELLITUS, TYPE 2; EUROPE; HUMANS; PATIENT CARE;

EID: 0032585856     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Hortulanus-Beck D, Lefebvre PJ, Jeanjean MF. Le diabète dans la province belge de Luxembourg: fréquence, importance de l'épreuve de surcharge glucosée orale et d'une glycémie à jeun discrètement accrue. Diabet Metab 1990; 16: 311-317.
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1994; 14: S7-S85.
3. Scheen AJ, Lefebvre PJ. (1998) Treatment of diabetes rnellitus. In: Sirtori CR (Ed). European Textbook of Clinical Pharmacology. McGraw-Hill.
4. Alberti KGMM, Gries FA, Jervell J, Krans HJM for the European NIDDM Policy Group. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. Diabet Med 1994; 11: 899-909.
5. Gudat U, Berger M, Lefebvre PJ. (1994) Physical activity, fitness and non-insulin-dependent (type II) diabetes mellitus. In: Bouchard C, Shephard RT, Stephens T. (Eds). Physical Activity, Fitness and Health. Champaign, Illinois, US. Human Kinetics. 669-683.
6. Scheen AJ, Lefebvre PJ. Oral antidiabetic agents: a guide to selection. Drugs 1998; 55: 225-236.
7. United Kingdom Prospective Diabetes Study Group. United Kingdom prospective study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed Type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998; 128: 165-175.
8. Duysinx B, Scheen AJ, Paquot N et al. Le diabète de type 2 insulinorequérant: caractéristiques des patients et effets de l'insulinothérapie. Rev Med Liege 1994; 49: 305-323.
9. Yki-Järvinen H, Ryysy L, Kauppila M et al. Effects of obesity on the response to insulin therapy in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 4037-4043.
10. Attali JR, Kleinebreil L, and the DIABCARE Centre in France. Comment les DID français sont-ils équilibrés: l'expérience de Diabcare France. J Ann Diabetol Hotel Dieu 1998; 281-288
11. Brennan GM, Boyle DIR, McMahon AD et al. Do patients with diabetes take their oral hypoglycaemic tablets? Diabetologia 1998; 41(Suppl 1): A61.
12. de Sonnaville JJJ, Bouma M, Colly LP et al. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study. Diabetologia 1997; 40: 1334-1340.
13. World Health Organization and International Diabetes Federation. Diabetes care and research in Europe: the St Vincent declaration. Diabet Med 1990; 7: 260
14. Krans HMJ, Porta M, Keen H, Staehr Johansen K Diabetes care and research in Europe: the St Vincent declaration implementation document G. Diabetologia 1995; 15(suppl 1).